LG Chem

Rhythm expands obesity portfolio with Phase II weight loss drug for $100m
Clinical Trials Arena
Fri, 01/5/24 - 11:21 am
Rhythm Pharmaceuticals
LG Chem
obesity
LB54640
Few signs of gout pipeline flaring up
EP Vantage
Thu, 05/18/23 - 10:45 am
gout
Selecta Biosciences
Sobi
SEL-212
3SBio
Amgen
Arthrosi Therapeutics
Atom Bioscience
Dyve Biosciences
Hinova Pharmaceuticals
Horizon Therapeutics
InventisBio
Jiangsu Hengrui Pharmaceuticals
JW Group
LG Chem
Olatec Therapeutics
Shanton Bioscience
Korean firm LG Chem buying AVEO Oncology for $566M
CP WIre
Tue, 10/18/22 - 01:57 pm
Aveo Oncology
M&A
oncology
cancer
Korea
LG Chem
Korean firm LG Chem buying AVEO Oncology for $566M
Tue, 10/18/22 - 01:55 pm
Aveo Oncology
M&A
oncology
cancer
Korea
LG Chem